Skip to content
Review Open access

Diagnostic performance of FAPI PET/CT for detecting peritoneal metastasis in gastric cancer: an exploratory prospective study and systematic review with meta-analysis

Oct 2026 · BMC Medical Imaging · 0 citations

TL;DR

Large-scale, well-designed prospective studies are needed to validate the diagnostic performance and clinical utility of FAPI PET/CT for detecting PM in gastric cancer and the wide confidence intervals surrounding the prospective estimates warrant cautious interpretation.

Abstract

Peritoneal metastasis (PM) in gastric cancer is associated with poor survival, but conventional imaging has limited sensitivity for its early detection. Although staging laparoscopy with peritoneal cytology, supplemented by histopathological examination of suspicious lesions when present, is considered the reference standard, it is invasive. Fibroblast activation protein (FAP), which is highly expressed in tumor stroma, can be targeted using FAP inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT). The high target-to-background contrast of FAPI PET/CT may improve PM detection; however, its diagnostic value in gastric cancer remains uncertain. We prospectively evaluated FAPI PET/CT for detecting PM in gastric cancer and conducted a systematic review and meta-analysis to comprehensively assess its diagnostic performance. We evaluated [¹⁸F]AlF-NOTA-FAPI-04 PET/CT for detecting peritoneal metastasis in gastric cancer in an exploratory prospective cohort using a laparoscopy-based composite reference standard. For the meta-analysis, PubMed, Embase, the Cochrane Library, and Web of Science were searched through July 10, 2026. Eligible studies evaluated FAPI-04 PET/CT and provided per-patient diagnostic 2 × 2 data. Risk of bias and applicability concerns were assessed using QUADAS-2. Pooled sensitivity and specificity were jointly estimated using a bivariate random-effects model. The primary analysis included datasets using a laparoscopy-based composite reference standard. Sensitivity analyses included datasets using multidisciplinary team-based assessment and all datasets eligible for bivariate pooling. Potential sources of heterogeneity were explored using separate univariable meta-regression models. In the exploratory prospective cohort, FAPI PET/CT yielded a sensitivity of 0.40 (95% CI, 0.12–0.77) and specificity of 1.00 (95% CI, 0.72–1.00). The accuracy was 0.80 (95% CI, 0.55–0.93), with a positive predictive value of 1.00 (95% CI, 0.34–1.00) and negative predictive value of 0.77 (95% CI, 0.50–0.92). In the primary meta-analysis of datasets using a laparoscopy-based composite reference standard, the pooled sensitivity was 0.66 (95% CI, 0.53–0.77), and the pooled specificity was 0.90 (95% CI, 0.76–0.96). In studies using multidisciplinary team-based assessment as the reference standard, the pooled sensitivity and specificity were 0.92 (95% CI, 0.85–0.96) and 0.98 (95% CI, 0.94–0.99), respectively. When all 11 datasets eligible for bivariate pooling were analyzed, irrespective of the reference standard used, the pooled sensitivity and specificity were 0.86 (95% CI, 0.75–0.92) and 0.96 (95% CI, 0.91–0.98), respectively. FAPI PET/CT demonstrated high specificity in the prospective cohort (1.00; 95% CI, 0.72–1.00) and primary meta-analysis (0.90; 95% CI, 0.76–0.96). However, sensitivity was lower in both the cohort (0.40; 95% CI, 0.12–0.77) and meta-analysis (0.66; 95% CI, 0.53–0.77). The wide confidence intervals surrounding the prospective estimates warrant cautious interpretation. Large-scale, well-designed prospective studies are needed to validate the diagnostic performance and clinical utility of FAPI PET/CT for detecting PM in gastric cancer.

Read PDF

Similar papers

Open access Oct 2026

The role of 18F-FDG PET/CT parameters in differentiating primary lung cancer from solitary lung metastasis in patients with colorectal cancer

Distant metastasis is the leading cause of death after curative resection for colorectal cancer (CRC). Accurately distinguishing primary lung cancer (PLC) from solitary lung metastasis (SLM) in patients with solitary pulmonary nodules (SPNs) remains clinically challenging due to the limitations of biopsy and conv...

Na Wang, Huan-Xin Zhu, Yu-Nuan Liu et al. · 0 citations
Oct 2026

68Ga-FAPI-04 PET/CT for Detection of Locoregional Lymph Node Metastases in Gynecologic Squamous Cell Carcinoma

In this small cohort, gallium-68 fibroblast activation protein inhibitor PET/CT showed a higher observed specificity than contrast-enhanced CT for the detection of locoregional LN metastases in gynecologic SCC, with no false-negative cases observed.

K. Michalski, A. Kosmala, P. Kohnle et al. · 0 citations
Nov 2026

Diagnostic performance of 18F-fluorodeoxyglucose PET/computed tomography in primary tumor localization and its impact on management in patients with metastases of unknown origin: a cross-sectional study.

AIM Metastases of unknown origin (MUO) remain a diagnostic challenge, with identification of the primary tumor closely tied to treatment planning and survival. This study aimed to evaluate the diagnostic performance of 18F-fluorodeoxyglucose PET/computed tomography (18F-FDG PET/CT) in detecting the primary tumor in MUO...

Hemat A. Mahmoud, E. Ibrahim, M. Mekkawy et al. · 0 citations
Review Open access Oct 2026

Evaluating [18F]-AlF-FAPI-74 PET/CT for diagnosis of the unfavourable CMS4 colorectal cancer subtype (FoCus study): protocol for a prospective, observational, proof-of-concept clinical study

Abstract Introduction Consensus molecular subtype 4 (CMS4) colorectal cancer (CRC) is characterised by stromal activation, therapy resistance and poor prognosis. Current CMS4 assessment relies on tissue sampling, which is limited by sampling bias due to inter-lesion and intra-lesion heterogeneity. Fibroblast activation...

M. van Duijvenvoorde, O. Kranenburg, Myrna van den Bos et al. · 0 citations
Open access Oct 2026

Early Dynamic 18F-FDG PET/CT SUVmax and Its Association with Pathological Stage and Tumor Grade in Bladder Cancer: A Prospective Exploratory Study

Early dynamic 18F-FDG PET/CT imaging at 0–2 min showed the highest, although modest, diagnostic performance among the evaluated time points for predicting tumor grade and muscle invasion.

B. Saylam, Berfin Temelli, Ali Nebi̇oğlu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.